This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: The Boots Company Plc, Fuisz Technologies Ltd.. Active years: 1989-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989-1998
Title: Mahendra Govind Pankhania: Innovator from Nottingham
Introduction
Mahendra Govind Pankhania is a notable inventor based in Nottingham, Great Britain. His work has led to the development of cutting-edge technologies, resulting in four patents that showcase his innovation in the pharmaceutical and materials science sectors.
Latest Patents
One of his latest inventions includes a patent for self-binding shearform compositions. These innovative shearform compositions, made without added glycerine, are designed to be self-binding and demonstrate exceptional cohesivity when utilized in tableting compositions. Typically, xylitol is integrated into a feedstock that undergoes flash-flow processing to create a self-binding shearform matrix. Another significant patent covers a sustained release pharmaceutical formulation that comprises xanthan gum combined with a pharmaceutically active ingredient such as ibuprofen or flurbiprofen, along with other optional excipients.
Career Highlights
Throughout his career, Mahendra has contributed to significant advancements in the field while working at reputable companies like The Boots Company Plc and Fuisz Technologies Ltd. His expertise in formulating and developing patented technologies has placed him at the forefront of innovation in the industry.
Collaborations
Collaboration has been a key part of Mahendra's career, enabling him to partner with notable professionals including Colin D Melia and John F Lampard. These collaborations have facilitated the exchange of ideas and knowledge, further advancing his innovative efforts.
Conclusion
Mahendra Govind Pankhania's contributions to science and innovation are evident through his patents and collaborative efforts. His work continues to make an impact, particularly in the pharmaceutical sector, paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile